Epilepsy, commonly known as crohn’s disease, is a neurological lesion, not a psychiatric disorder, with recurrent seizures. Epilepsy is divided into primary epilepsy and secondary epilepsy. The former is defined as those with an onset under 25 years of age, seizures in the form of grand or petit mal seizures, no limited brain damage on EEG and neurological examination, and no clear cause found. Secondary epilepsy is easy to understand and will not be described here. Epilepsy has a genetic predisposition The magnitude of the genetic effect is related to the cause of epilepsy, with primary epilepsy being higher than secondary epilepsy, and the closer the blood relationship the higher the prevalence. In addition, if both parents have epilepsy or have a child with epilepsy, the incidence of epilepsy increases to 20% in the third generation. Therefore, although patients with primary epilepsy may marry, they should limit their fertility. When choosing a spouse, epileptic patients should be careful not to marry a subject with a history of epilepsy and febrile convulsions in the family or in themselves; it is not advisable to marry a person with close blood ties. Antiepileptic drugs have an effect on pregnant women Studies have shown that 45% of epileptic patients have an increased number of seizures after pregnancy. This is mainly due to fluid retention after pregnancy and accelerated metabolism of drugs in the liver, resulting in lower serum concentrations of antiepileptic drugs. The number of seizures and the increased severity of seizures are closely related to the degree of seizure control prior to pregnancy. Therefore, epileptic patients must be prepared for pregnancy and achieve at least 1 year of strict control. Given that increasing the amount of antiepileptic drugs may have adverse effects on the mother and fetus, the blood concentration of antiepileptic drugs should be measured frequently after pregnancy, and if it is below the effective drug level, the dosage may be increased appropriately. The incidence of teratogenicity of antiepileptic drugs is 2.2%-13.8%, and common malformations include cleft palate, cleft lip, and heart abnormalities. This is related to the mother’s age of pregnancy, family history of congenital malformations, and diabetes mellitus on the one hand, and the drugs used on the other. In conclusion, the teratogenic risk of antiepileptic drugs is not significant. To prevent the occurrence of teratogenicity, it is appropriate to conceive after more than 3 years of epilepsy control and drug discontinuation or dose reduction; the drug used during pregnancy should be single and low dosage is appropriate. The first of these is the fact that the patient has a history of spontaneous abortion, stillbirth, stillbirth, fetal malformation, and so on. Finally, there are two more things to say. One is that women who are taking anti-epileptic drugs should not breastfeed. This is because babies excrete slowly and inhaling breast milk containing antiepileptic drugs can be very harmful to them; secondly, bad emotions can trigger seizures. Therefore, patients and the relatives and friends around them should maintain a good state of mind and communicate promptly when they encounter problems or difficulties. Especially during pregnancy, patients should pay more attention to regulating their mood to reduce seizures and make their babies grow up healthy.